Livongo Health (NASDAQ:LVGO) Expected to Post Earnings of -$0.14 Per Share

Share on StockTwits

Equities analysts expect that Livongo Health (NASDAQ:LVGO) will report ($0.14) earnings per share (EPS) for the current quarter, according to Zacks. Four analysts have made estimates for Livongo Health’s earnings, with estimates ranging from ($0.16) to ($0.13). The firm is scheduled to announce its next quarterly earnings report on Thursday, December 5th.

On average, analysts expect that Livongo Health will report full year earnings of ($0.72) per share for the current year, with EPS estimates ranging from ($0.82) to ($0.65). For the next year, analysts expect that the company will report earnings of ($0.32) per share, with EPS estimates ranging from ($0.36) to ($0.27). Zacks’ EPS averages are an average based on a survey of sell-side analysts that follow Livongo Health.

Livongo Health (NASDAQ:LVGO) last announced its quarterly earnings results on Thursday, September 5th. The company reported ($0.46) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.17) by ($0.29). The firm had revenue of $40.90 million for the quarter, compared to analysts’ expectations of $39.74 million. The company’s quarterly revenue was up 155.6% on a year-over-year basis.

A number of equities analysts recently issued reports on LVGO shares. Needham & Company LLC started coverage on shares of Livongo Health in a report on Monday, August 19th. They issued a “buy” rating and a $42.00 price objective on the stock. Chardan Capital started coverage on shares of Livongo Health in a report on Friday, August 16th. They issued a “neutral” rating and a $40.00 price objective on the stock. Goldman Sachs Group started coverage on shares of Livongo Health in a report on Monday, August 19th. They issued a “buy” rating and a $43.00 price objective on the stock. Canaccord Genuity started coverage on shares of Livongo Health in a report on Monday, August 19th. They issued a “buy” rating and a $46.00 price objective on the stock. Finally, Morgan Stanley raised shares of Livongo Health from an “equal weight” rating to an “overweight” rating and set a $42.00 price objective on the stock in a report on Wednesday, August 28th. One investment analyst has rated the stock with a hold rating and nine have given a buy rating to the company. Livongo Health presently has an average rating of “Buy” and a consensus target price of $44.20.

In other Livongo Health news, Director Hemant Taneja bought 2,678,571 shares of the business’s stock in a transaction that occurred on Monday, July 29th. The stock was purchased at an average cost of $28.00 per share, with a total value of $74,999,988.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, major shareholder Ab (Publ) Kinnevik bought 3,141,795 shares of the business’s stock in a transaction that occurred on Monday, July 29th. The stock was acquired at an average cost of $28.00 per share, with a total value of $87,970,260.00. The disclosure for this purchase can be found here. In the last quarter, insiders have bought 5,826,366 shares of company stock worth $162,980,808.

Shares of LVGO traded up $0.80 on Monday, reaching $23.86. The company’s stock had a trading volume of 618,147 shares, compared to its average volume of 1,118,287. The company’s 50 day moving average price is $31.60. Livongo Health has a 12-month low of $21.90 and a 12-month high of $45.68.

Livongo Health Company Profile

Livongo Health, Inc provides an integrated suite of solutions for the healthcare industry in North America. It solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science. The company offers a platform that provides cellular-connected devices, supplies, informed coaching, data science-enabled insights, and facilitates access to medications.

Featured Story: Day Trading

Get a free copy of the Zacks research report on Livongo Health (LVGO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Livongo Health (NASDAQ:LVGO)

Receive News & Ratings for Livongo Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livongo Health and related companies with MarketBeat.com's FREE daily email newsletter.